Comparable stake leader
Rainforest Capital VCC
SEC ownership of Basel Medical Group Ltd
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002004489.
Disclosed value leader
Rainforest Capital VCC
Comparable rows
3/4
Latest evidence
30 Jun 2026
- Public ticker
- BMGL on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Rainforest Capital VCC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
3 of 4
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Rainforest Capital VCC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0002004489
- Issuer location
- Singapore, Singapore
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Basel Medical Group Ltd (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rainforest Capital VCC
Disclosed value leader
Rainforest Capital VCC
Comparable rows
3/4
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 54%
1 rows are not safely comparable across share classes.
13D/G row: Rainforest Capital VCC
Quick read
Rainforest Capital VCC leads the comparable SEC ownership view at 54%.
3 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rainforest Capital VCC's linked filing trail.
Comparable ownership
Top 3
Rainforest Capital VCC
54%
Keng Leong Fung
54%
Tan Boon Chye
54%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rainforest Capital VCC |
13D/G
|
54%
|
$44,768,148
10,174,579 shares
|
$0 | 21 Feb 2025 |
| Keng Leong Fung |
3/4/5
Director
|
54%
|
$5,000,562
10,205,229 shares
|
— | 18 Mar 2026 |
| Tan Boon Chye |
3/4/5
Chief Commercial Officer, Director
|
54%
|
$5,000,562
10,205,229 shares
|
— | 18 Mar 2026 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$3,440
495 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to Basel Medical Group Ltd. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Tan Boon Chye
Net 12M change
$0
Latest report
05 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Tan Boon Chye | Chief Commercial Officer, Director | $5,000,562 | Mixed | 18 Mar 2026 | ||
| Keng Leong Fung | Director | $5,000,562 | Mixed | 18 Mar 2026 | ||
| Tony Chen | Director | Mixed | 18 Mar 2026 | |||
| Jianing Jn Lu | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Kwek Yoon Soong | Director | Mixed | 18 Mar 2026 | |||
| Paul D. Freudenthaler | Director | Mixed | 18 Feb 2025 | |||
| Alton Neo Chun How | Interim CFO | Mixed | 05 Jun 2026 | |||
| Darren Yen Feng Chhoa | Chief Executive Officer | Mixed | 18 Mar 2026 |
Recent insider transactions for Basel Medical Group Ltd
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Tan Boon Chye | BMGL | Ordinary shares with no par value | 0 | 10,205,229 | 18 Mar 2026 | See footnote | ||||
| Keng Leong Fung | BMGL | Ordinary shares with no par value | 0 | 10,205,229 | 18 Mar 2026 | See footnote |
* marks a reported price that did not pass the local price check.